The EU’s Pharmaceutical Strategy must do more to support nanomedicines and protect patient safety. Here’s why. Mike Isles is the Executive Director of the European Alliance for Access to Safe Medicines (EAASM). If Europe is to make its world-leading pharmaceutical...
